Posted: December 11, 2019
Stephen M. Hahn, MD, FASTRO, has been nominated to be the next commissioner of the U.S. Food and Drug Administration by President Trump. If approved by the Senate, Dr. Hahn will vacate his position as chief executive officer of The University of Texas MD Anderson Cancer Center, which he has held since 2017. He is also the Gilbert H. Fletcher Memorial Distinguished Chair and professor of radiation oncology there. Previously, he was the chair of Radiation Oncology at the University of Pennsylvania. Dr. Hahn specializes in lung cancer and sarcoma.